CSE CALI  |  Last $0.40  |  Change 0.03 OTC FNNZF  |  Last $0.32  |  Change 0.04

Our Mission is to combine extensive investment expertise, and industry experience in funding best-in-class businesses in the U.S. licensed medical cannabis industry with a focus on California.

The Company’s vision is to be the capital partner of choice for high growth, best-in-class businesses focused on the licensed U.S. medical cannabis industry

Why Are We Focused on Licensed Medical Cannabis?

According to analysts at Ameri Research, the global market for licensed medical cannabis is growing at a compound annual rate of more than 21.1%, and is on track to exceed $63.5 billion by 2024.

FinCanna is focused on this sector and is confident that its investors and portfolio companies will benefit from this focus.

FinCanna is focusing initially on California since it is the sixth largest economy in the world and the largest medical cannabis market in North America. At Arcview Group, Analysts estimate the California’s legal cannabis industry will grow at a 21.1% CAGR to $6.5 billion by 2020, and generate upwards of $1 billion in tax revenue.

The U.S. Cannabis Industry and California

  • USA Cannabis Market is predicted to become a $50 billion industry by 2026.(1)
  • California is the largest cannabis market in North America, representing over 30% of legal U.S. cannabis sales in 2016. (2)
  • California passed the Adult Use of Cannabis Act in November 2016. In 2018 new regulations come into effect whereby only permit holders can participate in the legal cannabis market, resulting in significant barriers to entry.
  • California, the most populous state in the U.S., in several years could bring in more than $1 billion in annual tax revenue, based on a forecast from the Tax Foundation. (3)

1 The Cowen Group, 2016
2 Arcview Market Research, 5th Edition
3 http://money.cnn.com/2016/11/09/news/economy/marijuana-legalization-sales/

Subscribe for Updates